Arginine Vasopressin Clinical Trials

All Categories Medications / Interventions » Aa » Arginine Vasopressin

Study Investigating the Impact Burden of Nocturia Using the Nocturia Impact Diary

Condition: Nocturia
Intervention: Drug: Desmopressin
Sponsors: Ferring Pharmaceuticals; Ferring Pharmaceuticals
Recruiting - verified April 2012
Vasopressin Administration During Laparoscopic Myomectomy: a Randomized Controlled Trial

Condition: Blood Loss, Surgical
Intervention: Drug: Vasopressin
Sponsors: Brigham and Women's Hospital; Brigham and Women's Hospital; Beth Israel Deaconess Medical Center; Northshore Medical Center; Cedars-Sinai Medical Center
Recruiting - verified May 2012
Oxytocin and Arginine Vasopressin in Pain Relief

Condition: Placebo Analgesia
Intervention:
Sponsors: National Institutes of Health Clinical Center (CC); National Institute of Mental Health (NIMH)
Recruiting - verified November 2011
Study of Dopamine Versus Vasopressin for Treatment of Low Blood Pressure in Low Birth Weight Infants

Condition: Hypotension
Interventions: Drug: Dopamine; Drug: Arginine Vasopressin
Sponsors: Baylor College of Medicine; Baylor College of Medicine; Thrasher Research Fund
Recruiting - verified June 2011
Hemofiltration in Burns: RESCUE (Randomized Controlled Evaluation of Hemofiltration in Adult Burn Patients With Septic Shock and Acute Renal Failure)

Conditions: Burns; Hemofiltration; Kidney Failure, Acute; Shock, Septic
Interventions: Device: An FDA approved continuous renal replacement device; Other: Control Group
Sponsors: United States Army Institute of Surgical Research; United States Army Institute of Surgical Research; American Burn Association; The University of Texas Health Science Center, Houston; Tampa General Hospital; Washington Hospital Center; Loyola University; University of Texas Southwestern Medical Center; Maricopa Integrated Health System; University of Tennessee Health Science Center
Recruiting - verified April 2012
Brain Imaging Study of Adults With Autism Spectrum Disorders

Condition: Autism Spectrum Disorders
Interventions: Drug: Oxytocin; Drug: Vasopressin
Sponsors: National Institutes of Health Clinical Center (CC); National Institute of Mental Health (NIMH)
Recruiting - verified June 2011
Efficacy and Safety of IL-11 in DDAVP Unresponsive

Conditions: Hemophilia A; Von Willebrand Disease
Intervention: Biological: Neumega (Oprelvekin, Interleukin 11, IL-11)
Sponsors: University of Pittsburgh; University of Pittsburgh
Recruiting - verified July 2011
Improving Platelet Activity for Cerebral Hemorrhage Treatment - DDAVP Proof of Concept

Condition: Intracerebral Hemorrhage
Intervention: Drug: DDAVP injection (desmopressin acetate)
Sponsors: Northwestern University; Northwestern University; Northwestern Memorial Hospital
Recruiting - verified March 2012
Treatment of Supine Hypertension in Autonomic Failure

Condition: Hypertension
Interventions: Drug: Clonidine; Drug: Nitroglycerin transdermal; Drug: Dipyridamole/ Aspirin (Aggrenox); Drug: Desmopressin (DDAVP); Drug: Sildenafil; Drug: Nifedipine; Drug: Hydralazine; Drug: Hydrochlorothiazide; Drug: Placebo; Drug: Bosentan; Drug: Diltiazem; Drug: Eplerenone; Drug: guanfacine; Dietary Supplement: L-arginine; Drug: captopril; Drug: carbidopa; Drug: losartan; Drug: metoprolol tartrate; Drug: nebivolol hydrochloride; Drug: prazosin hydrochloride; Drug: tamsulosin hydrochloride; Other: Head-up tilt.
Sponsors: Vanderbilt University; Vanderbilt University
Recruiting - verified May 2012